The Boulder Facility offers a significantly larger production scale for mammalian-based projects. The site houses two massive stainless steel cell bioreactors, and its size, automation, and cost-effective capabilities make it well-suited for high-volume commercial production and high titer antibody processes. In addition to cGMP commercial services, the site has a stellar track record in cell line development and experience with multiple mammalian cell types and expression systems.
Tony Fraij
